Home > Income Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Revenue

    Back to Income Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Net Sales ₹951 Cr₹937 Cr₹763 Cr₹667 Cr₹527 Cr

What is the latest Revenue of NEULAND LABORATORIES ?

The latest Revenue ratio of NEULAND LABORATORIES is ₹951 Cr based on Mar2023 Consolidated results.
Year Revenue
Mar2023₹951 Cr
Mar2022₹937 Cr
Mar2021₹763 Cr
Mar2020₹667 Cr
Mar2019₹527 Cr

How is Revenue of NEULAND LABORATORIES Trending?

Years Revenue % Change
Mar2023 ₹951 Cr
1.51
Mar2022 ₹937 Cr
22.84
Mar2021 ₹763 Cr
14.38
Mar2020 ₹667 Cr
26.44
Mar2019 ₹527 Cr -

Compare Revenue of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹9,652.1 Cr 8% 20.3% 258.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

8%

20.3%

258.5%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses